IL1A and psoriasis: BAIAP2 has been shown to control the expression of the proinflammatory cytokines IL-6 and IL-1α (57), and PRKCZ has been noted to play a role in controlling inflammatory dermal mesenchymal stem cells in psoriasis, a T cell-mediated disease (58).